Delivery Order SPE2DB22D2103-SPE2DB23FR8YU
Award Date 4/14/23
Potential Completion Date 4/17/23
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract has a Firm Fixed Price pricing type, a ceiling value of $10,672.96, and a period of performance through July 17, 2025. The contract is not designated as a set-aside....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fenofibrate 48 mg tablets. The contract has a ceiling value of $1,713.70 and is a firm fixed price delivery order with an ultimate completion date of August 22, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for the delivery of a wide...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,367.88 firm-fixed-price contract is for the delivery of fenofibrate 160 mg tablets to support federal healthcare programs. The contract is not designated as a set-aside and appears to be an open competition award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglycerides. The contract has a ceiling value of $7,245.44 and a completion date of June 11, 2025. It is a firm-fixed-price contract, which means the price will not change regardless of the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fenofibrate 145 mg tablets. The contract has a ceiling value of $1,872.56 and a period of performance through May 2024. It is a firm-fixed-price contract with no set-aside designation, indicating full and open competition. Amerisourcebergen is the prime contractor for this award, which is part of a larger Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Fenofibrate 40 mg tablets. The contract, which is not set aside, has a ceiling value of $1,409.52 and a performance period through June 10, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fenofibrate 67 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $1,468.64. The award was made on January 2, 2026, with an ultimate completion date of January 5, 2026. This non-set-aside contract represents a direct competitive award to the prime contractor, with performance of the delivery order taking place at AmerisourceBergen's corporate office...
- This federal contract award, identified as SPE2DB22D1041|SPE2DB23FP5QR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,632.72 Firm Fixed Price Delivery Order is for the supply of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The award is not designated under any set-aside program and represents open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Fenofibrate 120 mg tablets (90-count units) with a ceiling value of $26,126.95. The contract employs firm fixed pricing and is classified as a non-set-aside, competitively awarded delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,595.75, is a delivery order for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is a firm fixed-price arrangement. This contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug...